Pharmacovigilance Market to $24.69B by 2035; Veeva Q1 Revenues Seen +12.2%
Global pharmacovigilance market projected to expand from $8.91B in 2025 to $24.69B by 2035 at 10.34% CAGR, with U.S. forecast at $9.48B; Phase IV surveillance and outsourcing lead segments. Veeva Systems is expected to report March 4 quarterly EPS of $1.92 (up 10.3% YOY) on revenues of $808.9M (up 12.2%).
1. Projected Pharmacovigilance Market Growth
Analysts forecast the global pharmacovigilance market to grow from $8.91 billion in 2025 to $24.69 billion by 2035 at a compound annual growth rate of 10.34%. The U.S. segment is expected to reach $9.48 billion, with Phase IV post-market surveillance and contract outsourcing services leading market share.
2. Veeva Systems Q1 Earnings Outlook
Veeva Systems, which offers cloud software for life sciences compliance and safety, is scheduled to release its quarterly results on March 4. Consensus estimates call for EPS of $1.92, up 10.3% year-over-year, on revenues of $808.9 million, reflecting 12.2% growth from the prior year period.